Promising COVID-19 treatment sends Seattle biotech company’s stock soaring

Aqeel August 10, 2020 0

Shares in Seattle biotech firm Omeros shot up more than 60% Monday after a preliminary trial suggested the company's new drug, narsoplimab, could boost survival rates for COVID-19 patients on respirators.

from The Seattle Times World – The Seattle Times https://ift.tt/3afF4yY

No comments

Subscribe to: Post Comments ( Atom )